Novel technological advances have allowed biologists to take a sharp turn in their approaches to decipher molecular function and basis of physiological and pathological mechanisms. This conference will bring together researchers who are applying and developing novel “OMICs” approaches with an ultimate goal of understanding the functions of genes & proteins of therapeutic importance. The aim of the conference is to assess the current state of the art for approaches to gain functional understanding of human diseases. The meeting will feature sessions on targeting the vulnerabilities of diseased cells, new technologies such as high-throughput CRISPR and RNAi screens, automated phenotyping, metabolomics, and chemical genomics, as well as bioinformatics approaches for biomedical research.

Split3   1

Confirmed speakers

Ruedi Aebersold (ETH Zurich, Switzerland) Margarida D. Amaral (University of Lisbon, Portugal)
Philippe Bastiaens (Max Planck Institute, Germany) Michael Hall (Biozentrum, Basel, Switzerland)
Patrick Hsu (Salk Institute, USA) Tony Hunter (Salk Institute, USA) EMBO Member
Geert Kops (Hubrecht Institute, Netherlands) Anita Kriško (MedILS, Croatia)
Bernhard Küster (Technische Universität München, Germany) Susan Michaelis (Johns Hopkins, USA)
Morag Park (McGill University, Canada) Terry Rabbitts (University of Oxford, UK)
Miroslav Radman (MedILS, Croatia) Uwe Sauer (ETH Zurich, Switzerland)
Klaus Seuwen (Novartis Pharma, Switzerland) Laurent Schwartz (University of Paris, France)
Maria Sibilia (University of Vienna, Austria) Igor Stagljar (University of Toronto, Canada)
Iva Tolić (Ruđer Bošković Institute, Croatia) Domagoj Vucic (Genentech, USA)
John Yates III (The Scripps Research Institute, USA) Marino Zerial (Max Planck, Dresden, Germany)  


Conference will be held in Split in MedILS Date: 03.-07.07.2017.

MedILS –Mediterranean Institute for Life Sciences

Meštrovićevo šetalište 45   HR 21000 Split      Republic of Croatia

tel: +385 (0)21 555 600   fax: +385 (0)21 555 605    e-mail: